-
Mashup Score: 21
A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome - 1 year(s) ago
DNA methylation, one of the best characterized epigenetic marks in the human genome, plays a pivotal role in gene transcription regulation and other biological processes in humans. On top of that, …
Source: Taylor & FrancisCategories: Future of Medicine, Latest HeadlinesTweet-
We are trendy ! Happy to learn that our validation of new @illumina EPIC DNA #methylation #microarray (900K EPIC v2) in Epigenetics journal @tandfonline is one of the hottest papers by @altmetric; great work by @A_Nogueca @carlosgarciapri @DamianaAlvarez1 https://t.co/yIXFqOLFeu https://t.co/4lGCzmoowt
-
-
Mashup Score: 2Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome - 1 year(s) ago
DNA methylation, one of the best characterized epigenetic marks in the human genome, plays a pivotal role in gene transcription regulation and other biological processes in humans. On top of that, …
Source: Taylor & FrancisCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome - 1 year(s) ago
Mouse has been extensively used as a model organism in many studies to characterize biological pathways and drug effects and to mimic human diseases. Similar DNA sequences between both species faci…
Source: Taylor & FrancisCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 5GEO Accession viewer - 2 year(s) ago
NCBI’s Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data.
Source: www.ncbi.nlm.nih.govCategories: Future of Medicine, Latest HeadlinesTweet-
Playing with machines! All the raw data of our #open article validating a comprehensive #mouse DNA #methylation #microarray @illumina, available at public functional genomics repository GEO, thus, #bioinformaticians can use it for further studies. Enjoy! https://t.co/85SWnqflGA https://t.co/kqgl4ozdgS
-
-
Mashup Score: 0Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome - 2 year(s) ago
(2022). Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome. Epigenetics. Ahead of Print.
Source: Taylor & FrancisCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome - 2 year(s) ago
(2022). Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome. Epigenetics. Ahead of Print.
Source: Taylor & FrancisCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The latest retrospective analysis of patients with prostate cancer has determined that Decipher testing is valuable in influencing treatment decisions.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Epigenomics - 3 year(s) ago
ISSN (print): 1750-1911 | ISSN (online): 1750-192XFrequency: 24 issues per year Impact Factor: 4.778 (2020) Epigenomics welcomes unsolicited article proposals. Email us today to discuss the suitability of your research and our options for authors, including our Accelerated Publication and Open Access services. Follow us on social media for the latest updates TwitterFollow on…
Source: www.futuremedicine.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Diagnostic yield of chromosomal microarray and trio whole exome sequencing in cryptogenic cerebral palsy - 3 year(s) ago
Objective To determine the yield of genetic diagnoses using chromosomal microarray (CMA) and trio whole exome sequencing (WES), separately and combined, among patients with cryptogenic cerebral palsy (CP). Methods Trio WES of patients with prior CMA analysis for cryptogenic CP, defined as disabling, non-progressive motor symptoms beginning before the age of 3 years without known cause. Results…
Source: Journal of Medical GeneticsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
#Microarray patches safe and effective for vaccinating children, trial shows @lshtmpress @TheLancet https://t.co/4Xvqvxwkl6